Ardent Health, Inc. (NYSE:ARDT) Receives Consensus Rating of “Hold” from Brokerages

Posted by Stanley Muller on Jun 23rd, 2026

Shares of Ardent Health, Inc. (NYSE:ARDT – Get Free Report) have been given an average rating of “Hold” by the fourteen research firms that are covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, five have issued a hold recommendation and seven have issued a buy recommendation on the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $14.2083.

A number of equities research analysts recently issued reports on the company. Wall Street Zen raised Ardent Health from a “hold” rating to a “buy” rating in a research note on Saturday, May 16th. Royal Bank Of Canada dropped their price target on Ardent Health from $14.00 to $13.00 and set an “outperform” rating for the company in a research report on Monday, March 9th. Weiss Ratings reissued a “sell (d+)” rating on shares of Ardent Health in a report on Friday, June 12th. UBS Group upped their price objective on Ardent Health from $13.00 to $13.50 and gave the company a “buy” rating in a research report on Thursday, May 7th. Finally, Leerink Partners decreased their price objective on Ardent Health from $16.00 to $15.00 and set an “outperform” rating on the stock in a research note on Friday, March 6th.

Get Our Latest Stock Report on Ardent Health

Ardent Health Stock Performance

NYSE:ARDT opened at $9.01 on Thursday. The company has a current ratio of 2.12, a quick ratio of 2.00 and a debt-to-equity ratio of 0.62. The company has a market capitalization of $1.29 billion, a P/E ratio of 9.48, a price-to-earnings-growth ratio of 2.01 and a beta of 0.84. The firm has a 50-day moving average price of $9.48 and a two-hundred day moving average price of $9.13. Ardent Health has a twelve month low of $7.71 and a twelve month high of $15.48.

Ardent Health (NYSE:ARDT – Get Free Report) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $0.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.18 by $0.10. Ardent Health had a net margin of 2.09% and a return on equity of 13.85%. The company had revenue of $1.60 billion for the quarter, compared to the consensus estimate of $1.58 billion. Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. As a group, research analysts expect that Ardent Health will post 1.11 earnings per share for the current fiscal year.

Insider Transactions at Ardent Health

In other news, CFO Alfred Lumsdaine purchased 10,000 shares of the firm’s stock in a transaction on Friday, June 5th. The shares were bought at an average cost of $8.81 per share, with a total value of $88,100.00. Following the purchase, the chief financial officer directly owned 329,183 shares of the company’s stock, valued at approximately $2,900,102.23. This trade represents a 3.13% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 1.90% of the company’s stock.

Hedge Funds Weigh In On Ardent Health

Several institutional investors and hedge funds have recently modified their holdings of the company. Goldentree Asset Management LP boosted its position in Ardent Health by 99.7% during the fourth quarter. Goldentree Asset Management LP now owns 2,303,113 shares of the company’s stock worth $20,302,000 after acquiring an additional 1,150,000 shares during the last quarter. Goldman Sachs Group Inc. lifted its stake in shares of Ardent Health by 1,684.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company’s stock worth $10,558,000 after purchasing an additional 724,841 shares during the period. Ameriprise Financial Inc. lifted its stake in shares of Ardent Health by 75.6% during the 2nd quarter. Ameriprise Financial Inc. now owns 1,634,822 shares of the company’s stock worth $22,332,000 after purchasing an additional 703,739 shares during the period. Bridgeway Capital Management LLC boosted its holdings in shares of Ardent Health by 108.2% during the fourth quarter. Bridgeway Capital Management LLC now owns 946,571 shares of the company’s stock worth $8,358,000 after purchasing an additional 491,961 shares during the last quarter. Finally, Hotchkis & Wiley Capital Management LLC acquired a new stake in shares of Ardent Health during the third quarter worth $6,377,000.

Ardent Health Company Profile

(Get Free Report)

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.